The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.50
Bid: 486.50
Ask: 489.00
Change: -0.50 (-0.10%)
Spread: 2.50 (0.514%)
Open: 485.00
High: 489.00
Low: 485.00
Prev. Close: 489.00
HGT Live PriceLast checked at -
HgCapital is an Investment Trust

To provide shareholders with long-term capital appreciation in excess of the FTSE All Share Index by investing in unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

24 Mar 2020 09:00

RNS Number : 2864H
HgCapital Trust PLC
24 March 2020
 

Update by the Board of HgCapital Trust plc (HGT) and the Investment Manager (Hg) to Shareholders on the potential effects of COVID-19 on HgCapital Trust

As the COVID-19 pandemic continues to unfold across the world, the Board of HGT and the investment manager, Hg would like to update you on what they believe may be the potential impacts for HgCapital Trust plc and the mitigations that have been made.

Hg invests in companies that focus on critical activities such as delivering legal, health and safety advice to many thousands of businesses globally, helping these companies to pay taxes and payroll, deliver healthcare services, audit and manage supply chains and provide many other services. These types of company and their business models are potentially less likely to be disrupted by the pandemic than the broader economy. Nonetheless, with a global recession now the backdrop for 2020, it is important to note the potential challenges ahead, recognising the importance of transparent communication to which the Board of HGT and Hg have always been committed.

Given the critical nature of software and services that our portfolio provides to the wider business world, Hg believes that there will be fewer direct impacts from the pandemic than you might see in a more generalist portfolio. Nevertheless, whilst Hg anticipates that the portfolio in aggregate will continue to deliver growth over the long-term, the Manager can see a scenario where a handful of the Hg investments potentially deliver year-on-year declines in performance and Hg are managing this appropriately.

Public market valuations overall have fallen sharply in recent weeks, with valuation multiples for the S&P500 returning to 2015 levels in EV:EBITDA terms. However, the S&P500 Software and Services index, which is more closely related to our portfolio, has returned only to 2017 valuation multiples. . Strong EBITDA growth across the Software and Services sector has tempered that valuation decline and thus asset values are similar to early 2019 levels. In such volatile markets, and with unpredictable trading results for many businesses, market valuation multiples need to be treated with caution. Hg will continue to stress test the portfolio, in order to identify any issues as early as possible.

In summary, Hg believes that there are likely to be short-term declines in the overall valuation of our portfolio and thus in the reported NAV of HGT. However, the long-term nature of listed private equity investment, the types of business that Hg invests in and the scale of the structural opportunities that these can deliver, will continue to drive long-term growth.

As manager, Hg has robust business continuity procedures allowing it to continue to provide active management of the portfolio and full support for the management teams of our portfolio companies, while working remotely. Hg's proprietary HgHive© online community now has a COVID-19 channel through which our portfolio companies can share best practice in dealing with the effects of the pandemic.

Hg will maintain a focus on the best course of action for society, for their employees and for the staff and businesses in which they invest, and continue to review the risk profile as this fast-moving situation develops.

 

Roger Mountford, Chairman, HgCapital Trust plc, said: "The Board remains confident in Hg's management of the portfolio and the ability of HGT as a long-term investment to continue to perform across all cycles. We have always been committed to transparent reporting to all our investors and will continue to monitor this situation and provide further updates whenever required".

 

HGT reported its 2019 full year results on 9 March 2020 and will provide a full revaluation of the portfolio up to 31 March on 11 May 2020.

Please do not hesitate to contact Laura Dixon (laura.dixon@hgcapital.com) if you have any questions.

 

For further details:

 

Hg

Laura Dixon +44 (0)20 7089 7888

 

Brunswick

Alice Gibb and Sam Chiene +44 (0)207 404 5959

 

About HgCapital Trust plc

 

HgCapital Trust plc, whose shares are listed on the London Stock Exchange (ticker: HGT.L), gives investors exposure through a liquid vehicle to a portfolio of high-growth private companies in the software and services sector. The selection of new investments and creation of value in these businesses are managed by Hg, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors. For further details, please see www.hgcapitaltrust.com.

 

The contents of the Hg and HgCapital Trust's websites are not incorporated into, and do not form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBIGDXIGDDGGX
Date   Source Headline
9th Sep 20197:00 amRNSHalf-year Report
9th Sep 20197:00 amRNSInterim Report and Accounts
5th Sep 20197:00 amRNSRegister Group joins team.blue
2nd Jul 201911:51 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights
26th Jun 20197:00 amRNSBlock Listing Application
18th Jun 201912:35 pmRNSHolding(s) in Company
17th Jun 20194:22 pmRNSHolding(s) in Company
14th Jun 20193:27 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSResult of Placing
10th Jun 20197:00 amRNSPlacing to raise up to approximately £80 million
7th Jun 20197:00 amRNSPerformance at Month End
28th May 20197:00 amRNSTotal Voting Rights after sub-division of shares
23rd May 20197:58 amRNSSub-Division of Shares
20th May 20195:07 pmRNSDirector/PDMR Shareholding - Replacement
17th May 20195:15 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSPerformance at Month End
7th May 20197:00 amRNSHg invests in Litera Microsystems
3rd May 20193:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20194:35 pmRNSResult of AGM
18th Apr 20197:00 amRNSHg purchases Cinven stake in Visma
9th Apr 20197:00 amRNSPerformance at Month End
22nd Mar 20194:55 pmRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSHg agrees the sale of Foundry
11th Mar 20197:00 amRNSAnnual Financial Report
11th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
29th Jan 20197:31 amRNSHg completes refinancing of A-Plan
29th Jan 20197:30 amRNSHg invests in Transporeon Group
22nd Jan 20192:14 pmRNSHolding(s) in Company
22nd Jan 20199:40 amRNSVisma welcomes CPPIB as new investor
21st Dec 20182:00 pmRNSHg invests in Combell Group
19th Dec 20185:01 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSPerformance at Month End
9th Nov 20189:28 amRNSHg agrees the sale of Atlas to Mintra Group
9th Nov 20187:00 amRNSPerformance at Month End
5th Nov 20185:11 pmRNSDirector/PDMR Shareholding
30th Oct 201812:19 pmRNSDirector/PDMR Shareholding - Replacement
30th Oct 201811:36 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSPerformance at Month End
1st Oct 20188:30 amRNSSale of Lumesse
10th Sep 20184:04 pmRNSDirector/PDMR Shareholding
10th Sep 20187:10 amRNSHg announces an investment in BrightPay
10th Sep 20187:00 amRNSHalf-year Report
10th Sep 20187:00 amRNSInterim Results - Six Months Ended 30 June 2018
30th Aug 20187:00 amRNSHg investment into Allocate Software from Hg8 Fund
20th Aug 201811:26 amRNSSyneos Health Acquires Kinapse
15th Jun 20187:00 amRNSPerformance at Month End
14th Jun 20187:30 amRNSHg invests in IT Relation
6th Jun 20188:00 amRNSHg agrees sale of Intelliflo to Invesco
29th May 20187:00 amRNSVisma Group intends to acquire Raet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.